This activity has expired. Credit is no longer available.
This activity is supported by an independent educational grant from Merck Sharp & Dohme Corp.
Applying Genomics to Rare Lymphomas and Leukemias (Hodgkin Lymphoma and Chronic Lymphocytic Leukemia)
Sandra E. Kurtin, PhDc, ANP-C, AOCN®
The University of Arizona Cancer Center
Ann McNeill, RN, MSN, APN
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
Review how genomics are being used to treat rare hematologic malignancies such as Hodgkin lymphoma, chronic lymphocytic leukemia, and mantle cell lymphoma. And learn how, as an advanced practitioner, to evaluate toxicities from these cutting-edge therapies and how to help patients navigate the potential side effects.
|
|
|
|
These activities, certified for CME/CE/CPE credit, are jointly provided by
  |